High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: The Rotterdam study

Diabetes Care

Volumn 36, Issue 6, 2013, Pages 1619-1628

  Oei, Ling ^a,b   Zillikens, M Carola ^a,b   Dehghan, Abbas ^a,b   Buitendijk, Gabriëlle H S ^a   Castaño Betancourt, Martha C ^a,b   Estrada, Karol ^a,b   Stolk, Lisette ^a,b   Oei, Edwin H G ^a   Van Meurs, Joyce B J ^a,b   Janssen, Joseph A M J L ^a   Hofman, Albert ^a,b   Van Leeuwen, Johannes P T M ^a   Witteman, Jacqueline C M ^a,b   Pols, Huibert A P ^a   Uitterlinden, André G ^a,b   Klaver, Caroline C W ^a   Franco, Oscar H ^a,b   Rivadeneira, Fernando ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS GENOMICS INITIATIVE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; HEMOGLOBIN A1C;

AGE; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL BONE; DIABETES CONTROL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK ASSESSMENT;

ABSORPTIOMETRY, PHOTON; AGED; BLOOD GLUCOSE; BONE DENSITY; DIABETES MELLITUS, TYPE 2; FEMALE; FEMUR NECK; FRACTURES, BONE; HEMOGLOBIN A, GLYCOSYLATED; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84877725305     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1188     Document Type: Article

References (49)

1. National Diabetes Statistics [article online], 2011. Available from http://diabetes.niddk.nih.gov/dm/pubs/statistics/. Accessed 1 July 2011
2. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-69
3. Ström O, Borgström F, Kanis J, et al. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations. Arch Osteoporos 2011;6:59-155
4. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495-505 (Pubitemid 47283633)
5. Schwartz AV, Vittinghoff E, Bauer DC, et al.; Study of Osteoporotic Fractures (SOF) Research Group; Osteoporotic Fractures in Men (MrOS) Research Group; Health, Aging, and Body Composition (Health ABC) Research Group. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 2011;305:2184-2192
6. Ma L, Oei L, Jiang L, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 2012;27:319-332
7. de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 2005;16:1713-1720 (Pubitemid 41790880)
8. Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 2012;27:301-308
9. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011;26:657-686
10. Stolk RP, Pols HA, Lamberts SW, de Jong PT, Hofman A, Grobbee DE. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. Am J Epidemiol 1997;145:24-32 (Pubitemid 27009054)
11. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163-167 (Pubitemid 36929010)
12. University of Maryland School of Medicine, Department of Epidemiology and Preventative Medicine. Early Treatment Diabetic Retinopathy Study (ETDRS). Manual of Operations. Baltimore, ETDRS Coordinating Center, 1980
13. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva, World Health Org., 1992
14. Burger H, de Laet CE, van Daele PL, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol 1998;147:871-879
15. Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW. Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 2000;15:2297-2304
16. Melton LJ 3rd, Beck TJ, Amin S, et al. Contributions of bone density and structure to fracture risk assessment in men and women. Osteoporos Int 2005;16:460-467
17. Rivadeneira F, Zillikens MC, De Laet CE, et al. Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study. J Bone Miner Res 2007;22:1781-1790 (Pubitemid 351235145)
18. Selvin E, Francis LM, Ballantyne CM, et al. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 2011;34:960-967
19. Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002;25:1749-1754 (Pubitemid 41071081)
20. Schwartz AV, Vittinghoff E, Sellmeyer DE, et al.; Health, Aging, and Body Composition Study. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008;31:391-396
21. Garg R, Chen Z, Beck T, et al. Hip geometry in diabetic women: implications for fracture risk. Metabolism 2012;61:1756-1762
22. Melton LJ 3rd, Riggs BL, Leibson CL, et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 2008;93:4804-4809
23. Petit MA, Paudel ML, Taylor BC, et al.; Osteoporotic Fractures in Men (MrOs) Study Group. Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 2010;25:285-291
24. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 2001;86:4576-4584 (Pubitemid 33020488)
25. Kanazawa I, Yamaguchi T, Sugimoto T. Serum insulin-like growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus. Growth Horm IGF Res 2011;21:268-271
26. Forsén L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey. Diabetologia 1999;42:920-925 (Pubitemid 29369598)
27. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ; Blue Mountains Eye Study. Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 2001;24:1198-1203 (Pubitemid 33716398)
28. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif Tissue Int 2008;83:324-331
29. Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008;23:1334-1342 (Pubitemid 352040189)
30. Strotmeyer ES, Cauley JA, Schwartz AV, et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 2005;165:1612-1617 (Pubitemid 41124155)
31. Benhalima K, Standl E, Mathieu C. The importance of glycemic control: how low should we go with HbA1c? Start early, go safe, go low. J Diabetes Complications 2011;25:202-207
32. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-489
33. Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2010;95:5045-5055
34. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med 2003;349:327-334 (Pubitemid 36886238)
35. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625 (Pubitemid 40770750)
36. Blakytny R, Spraul M, Jude EB. Review: the diabetic bone: a cellular and molecular perspective. Int J Low Extrem Wounds 2011;10:16-32
37. Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 1993;123(Suppl.):465-468 (Pubitemid 23073274)
38. Yamaguchi T, Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus [Review]. Endocr J 2011;58:613-624
39. Schurman L, McCarthy AD, Sedlinsky C, et al. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes 2008;116:333-340 (Pubitemid 351947863)
40. Zhou Z, Immel D, Xi CX, et al. Regulation of osteoclast function and bone mass by RAGE. J Exp Med 2006;203:1067-1080
41. Mohan S, Richman C, Guo R, et al. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 2003;144:929-936 (Pubitemid 36262860)
42. Libanati C, Baylink DJ, Lois-Wenzel E, Srinvasan N, Mohan S. Studies on the potential mediators of skeletal changes occurring during puberty in girls. J Clin Endocrinol Metab 1999;84:2807-2814 (Pubitemid 30642017)
43. Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S. Clinical review: sex steroids and the periosteum - reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 2006;91:378-382 (Pubitemid 43236896)
44. Chestnut RE, Quarmby V. Evaluation of total IGF-I assay methods using samples from type I and type II diabetic patients. J Immunol Methods 2002;259:11-24 (Pubitemid 33124380)
45. Clauson PG, Brismar K, Hall K, Linnarsson R, Grill V. Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scand J Clin Lab Invest 1998;58:353-360 (Pubitemid 28396224)
46. Sesti G, Sciacqua A, Cardellini M, et al. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005;28:120-125 (Pubitemid 40095793)
47. Schwartz AV, Margolis KL, Sellmeyer DE, et al. Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care 2012;35:1525-1531
48. Vadstrup ES, Frølich A, Perrild H, Borg E, Røder M. Health-related quality of life and self-related health in patients with type 2 diabetes: effects of group-based rehabilitation versus individual counselling. Health Qual Life Outcomes 2011;9:110
49. Habib ZA, Havstad SL,Wells K, Divine G, Pladevall M, Williams LK. Thiazolidine-dione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2010;95:592-600